Myocardial Calcium Handling in Type 2 Diabetes: A Novel Therapeutic Target

被引:1
作者
Dattani, Abhishek [1 ]
Singh, Anvesha
Mccann, Gerry P.
Gulsin, Gaurav S.
机构
[1] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, England
关键词
diabetes; calcium handling; manganese-enhanced MRI; GLYCATION END-PRODUCTS; SARCOPLASMIC-RETICULUM CA2+-ATPASE; CONGESTIVE-HEART-FAILURE; DIASTOLIC DYSFUNCTION; VENTRICULAR MYOCYTES; CARDIAC STRUCTURE; GENE-EXPRESSION; MANGANESE IONS; YOUNG-ADULTS; CARDIOMYOPATHY;
D O I
10.3390/jcdd11010012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes (T2D) is a multisystem disease with rapidly increasing global prevalence. Heart failure has emerged as a major complication of T2D. Dysregulated myocardial calcium handling is evident in the failing heart and this may be a key driver of cardiomyopathy in T2D, but until recently this has only been demonstrated in animal models. In this review, we describe the physiological concepts behind calcium handling within the cardiomyocyte and the application of novel imaging techniques for the quantification of myocardial calcium uptake. We take an in-depth look at the evidence for the impairment of calcium handling in T2D using pre-clinical models as well as in vivo studies, following which we discuss potential novel therapeutic approaches targeting dysregulated myocardial calcium handling in T2D.
引用
收藏
页数:19
相关论文
共 50 条
  • [41] Macrophage peroxisome proliferator activated receptor γ as a therapeutic target to combat Type 2 diabetes
    Pascual, Gabriel
    Ricote, Mercedes
    Hevener, Andrea L.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2007, 11 (11) : 1503 - 1520
  • [42] Dipeptidyl peptidase Ⅳ(DPP Ⅳ):a novel emerging target for thetreatment of type 2 diabetes
    Jing Wua
    bDepartment of Oncology
    The Journal of Biomedical Research, 2009, (04) : 228 - 235
  • [43] Incretin mimetics: a novel therapeutic option for patients with type 2 diabetes - a review
    Hansen, Katrine B.
    Vilsboll, Tina
    Knop, Filip K.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2010, 3 : 155 - 163
  • [44] Influence of Obesity and Type 2 Diabetes on Calcium Handling by Skeletal Muscle: Spotlight on the Sarcoplasmic Reticulum and Mitochondria
    Eshima, Hiroaki
    FRONTIERS IN PHYSIOLOGY, 2021, 12
  • [45] Propagermanium as a Novel Therapeutic Approach for the Treatment of Endothelial Dysfunction in Type 2 Diabetes
    Azul, Lara
    Leandro, Adriana
    Seica, Raquel
    Sena, Cristina M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (15)
  • [46] Predictive value of echocardiography in Type 2 diabetes
    Jorgensen, Peter G.
    Biering-Sorensen, Tor
    Mogelvang, Rasmus
    Fritz-Hansen, Thomas
    Vilsboll, Tina
    Rossing, Peter
    Jensen, Magnus T.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2019, 20 (06) : 687 - 693
  • [47] APJ RECEPTOR: A NOVEL THERAPEUTIC TARGET FOR DIABETES AND DIABETIC COMPLICATIONS
    Hu, Haoliang
    Chen, Bo
    Zhou, Xi
    Tang, Dongfang
    Zhang, Yunxiao
    Zhang, Peng
    Xiao, Zhen
    Yan, Yujie
    Zhou, Zhefei
    Chen, Yi
    Chen, Minzhi
    Tang, Cheng
    Liu, Zhonghua
    TOXICON, 2019, 158 : S85 - S85
  • [48] Omentin: A novel therapeutic approach for the treatment of endothelial dysfunction in type 2 diabetes
    Leandro, Adriana
    Queiroz, Marcelo
    Azul, Lara
    Seica, Raquel
    Sena, Cristina M.
    FREE RADICAL BIOLOGY AND MEDICINE, 2021, 162 : 233 - 242
  • [49] Bcl10 and methylation of fatty acids: a future therapeutic target for Type 2 diabetes?
    Jornayvaz, Francois R.
    CLINICAL LIPIDOLOGY, 2012, 7 (05) : 493 - 495
  • [50] GATA-3 as a Potential Therapeutic Target for Insulin Resistance and Type 2 Diabetes Mellitus
    Al-Jaber, Hend
    Al-Mansoori, Layla
    Elrayess, Mohamed A.
    CURRENT DIABETES REVIEWS, 2021, 17 (02) : 169 - 179